LAS VEGAS, April 24, 2017 -- We are pleased to announce, THC Therapeutics (THCT) will be a participant in the Cannabis investing event at this year's Money Show in Las Vegas NV at Caesars Palace. We’ll have a booth alongside three other publicly traded companies in the cannabis space. Brandon Romanek, our Founder & CEO will be participating in a Cannabis symposium along with other executives in the Cannabis industry on May 16th, 2017, 3:40 PM - 4:25 PM. Shortly after the Symposium at 5:05 PM - 5:25 PM, Romanek will be giving a detailed presentation about THC Therapeutics. There will be over 3500 attendants to this year's conference. We look forward to seeing all our current shareholders and new investors to come.
Participants can attend the show free of charge. Visit their website here - https://www.moneyshow.com/events/conferences/the-moneyshow/moneyshow-las-vegas/
Comments from Brandon Romanek, “I am very excited for THCT to be a participant at this year's Money Show in Las Vegas. Over the past 17+ years, I have been going to many of their events as a trader, investor and portfolio manager. For an investor and trader, this is a phenomenal opportunity to gain a wealth of knowledge. You will meet and greet executives of publicly traded companies and some of the foremost financial experts in the world."
Romanek Continues, “At the time of this show, we’ll have been a publicly traded company for less than 4 months, I cannot think of a better way to introduce THC Therapeutics to sophisticated investors and traders. This conference will definitely put us on the radar. Our participation in this event will be the first of many. Please come by our booth and meet the THC Therapeutics team. I look forward to seeing all of our shareholders and introducing THC Therapeutics to the masses.”
About THC Therapeutics:
THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has "Better Health through the Science of Nature" as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics' plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.
Forward-Looking Statements Disclosure:
This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Phone: 702.602.THCC (8422)
Follow Brandon Romanek on Twitter:
Twitter @BrandonRomanek
Follow THC Therapeutics on Facebook and Twitter:
Facebook @THCTherapies
Twitter @THCTherapeutics


Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Google Secures Pentagon AI Deal for Classified Projects
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 



